Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
BOOST logo

The Better Outcomes for Older people with Spinal Trouble (BOOST) trial has opened its first pilot site for recruitment. The Royal Orthopaedic Hospital in Birmingham is now recruiting patients for the trial which is studying different physiotherapy treatments for people who suffer back and leg pain due to lumbar spinal stenosis. The trial will be gradually rolled out across at least 10 hospitals in England over the next 6 months.

 

Participants who are aged 65 and over, registered with a Primary Care practice and report symptoms consistent with neurogenic claudication may be eligible to join the trial as a participant. The trial’s primary outcome is to evaluate the clinical and cost-effectiveness of a physiotherapy rehabilitation programme for people with lower back and leg pain compared to usual care.

 

The BOOST trial is part of a wider programme of research looking at pain and physical activity in older people.

 

For more information please visit www.boosttrial.org.uk

Similar stories

SCIENCE spreads across the world

Oxford Trauma are pleased to open their first overseas site for the SCIENCE study.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

PRoCuRe opens to recruitment

The Partial Rotator Cuff Tear Repair Trial (PRoCuRe) is open to recruitment at Oxford University Hospitals NHS Foundation Trust after achieving OCTRU Green Light approval!

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.